Andrew Denker

Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: I. Stimulation by bone morphogenetic protein-2 in high-density micromass cultures

Andrew Denker, Andrew R. Haas, Steven B. Nicoll et al. · Differentiation · 1999 · 255 citations

Regenerative Medicine, Developmental Biology, Bone Biology +13

Formation of cartilage-like spheroids by micromass cultures of murine C3H10T1/2 cells upon treatment with transforming growth factor-β1

Andrew Denker, Steven B. Nicoll, Rocky S. Tuan · Differentiation · 1995 · 200 citations

Tissue Engineering, Regenerative Medicine, Engineering +12

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study

Bente Langdahl, Neil Binkley, Henry G. Bone et al. · Journal of Bone and Mineral Research · 2012 · 160 citations

Osteopathy, Gynecology, Continued Therapy +16

Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia

Priya S. Kishnani, Cheryl R. Greenberg, Frank Rauch et al. · Bone · 2018 · 142 citations · Full text

The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment

Gema Ariceta, Bradley P. Dixon, Seong Heon Kim et al. · Kidney International · 2020 · 80 citations · Full text